These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27716513)

  • 21. Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
    Gommoll C; Forero G; Mathews M; Nunez R; Tang X; Durgam S; Sambunaris A
    Int Clin Psychopharmacol; 2015 Nov; 30(6):297-306. PubMed ID: 26291335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
    Merideth C; Cutler AJ; She F; Eriksson H
    Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
    Mahableshwarkar AR; Jacobsen PL; Serenko M; Chen Y
    Hum Psychopharmacol; 2014 Jan; 29(1):64-72. PubMed ID: 24424707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.
    Fresquet A; Sust M; Lloret A; Murphy MF; Carter FJ; Campbell GM; Marion-Landais G
    Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder: A Randomized Clinical Trial.
    Brenes GA; Danhauer SC; Lyles MF; Hogan PE; Miller ME
    JAMA Psychiatry; 2015 Oct; 72(10):1012-20. PubMed ID: 26244854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.
    Akhondzadeh S; Naghavi HR; Vazirian M; Shayeganpour A; Rashidi H; Khani M
    J Clin Pharm Ther; 2001 Oct; 26(5):363-7. PubMed ID: 11679026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
    Ruiz MA; Álvarez E; Carrasco JL; Olivares JM; Pérez M; Rejas J
    Drug Des Devel Ther; 2015; 9():4329-40. PubMed ID: 26273194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M; Klimm HD
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explanatory attributions of anxiety and recovery in a study of kava.
    Abraham KC; Connor KM; Davidson JR
    J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.
    Kasper S; Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):859-69. PubMed ID: 24456909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
    Ooi SL; Henderson P; Pak SC
    J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
    Coric V; Feldman HH; Oren DA; Shekhar A; Pultz J; Dockens RC; Wu X; Gentile KA; Huang SP; Emison E; Delmonte T; D'Souza BB; Zimbroff DL; Grebb JA; Goddard AW; Stock EG
    Depress Anxiety; 2010 May; 27(5):417-25. PubMed ID: 20455246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial.
    Park DM; Kim SH; Park YC; Kang WC; Lee SR; Jung IC
    J Ethnopharmacol; 2014 Dec; 158 Pt A():11-7. PubMed ID: 25456420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.